Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A media release issued by EDAP TMS SA – the developer and distributor of the Ablatherm® technology used in high-intensity focused ultrasound (HIFU) treatment of men with prostate cancer – states that a review of 15 years experience with Ablatherm technology will be published in the June issue of Current Urology Reports.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Ablatherm, HIFU, high-intensity focused ultrasound, review | Leave a Comment »
In today’s news there are reports on: Initial diagnosis of intraductal carcinoma of the prostate An aborted trial of HIFU using the Ablatherm device Late rectal complications after prostate brachytherapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Ablatherm, brachytherapy, carcinoma, complications, HIFU, high-intensity focused ultrasound, intraductal, rectal | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site